Source: Annual Congress 2001 - Respiratory measurements (from FEV₁ to respiratory resistance)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Shakespeare, R. A. Stockley, S. L. Hill (Birmingham, United Kingdom). Use of measurements of airway resistance in the determination of reversibility in patients with emphysema associated with alpha-1-antitrypsin (A1ATD) deficiency. Eur Respir J 2001; 16: Suppl. 31, 1436

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Increased airway resistance in asthma and emphysema and its relation to other pulmonary function tests Source: Eur Respir J 2007; 30: Suppl. 51, 618s Year: 2007 Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2015 – IPF pathogenesis Year: 2015 Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Higher than expected prevalence of alpha-1-antitrypsin deficiency (AATD) may not necessarily impact on airflow, gas exchange or acute exacerbation rate (AER) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009 Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres Source: Eur Respir J 2010; 35: 960-968 Year: 2010 Exploring the relationship between alpha-1-antitrypsin deficiency and persistent airflow limitation in severe asthma. Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Airway neutrophilia in chronic airways disease (CAD) is associated with lower lung function and reduced soluble(s)RAGE Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Decline in lung function in patients with alpha-1-antitrypsin deficiency and airflow obstruction Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014 Efficacy of augmentation therapy for emphysema associated with alpha1-antitrypsin deficiency: enough is enough Source: Eur Respir J 2016; 47: 35-38 Year: 2016 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001